UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
CALL
Fortis
FTS
$28.3B
| $1.04M | ﹤0.01% |
+25,000
| New | +$1.02M |
|
4177
DMC Global
BOOM
$153M
| $1.04M | ﹤0.01% |
23,068
+10,559
| +84% | +$469K |
|
4178
Ambarella
AMBA
$3.6B
| $1.04M | ﹤0.01% |
17,111
-1,252
| -7% | -$69.3K |
|
4179
CALL
Bunge Global
BG
$21.6B
| $1.04M | ﹤0.01% |
18,000
+15,000
| +500% | +$830K |
|
4180
Tredegar Corp
TG
$292M
| $1.04M | ﹤0.01% |
46,341
+13,300
| +40% | +$279K |
|
4181
Bank First Corp
BFC
$1.69B
| $1.03M | ﹤0.01% |
14,786
+9,680
| +190% | +$661K |
|
4182
Collegium Pharmaceutical
COLL
$882M
| $1.03M | ﹤0.01% |
50,261
+20,811
| +71% | +$347K |
|
4183
Tidewater
TDW
$4.46B
| $1.03M | ﹤0.01% |
53,574
+15,507
| +41% | +$248K |
|
|
BHR
4184
Braemar Hotels & Resorts
BHR
$139M
| $1.03M | ﹤0.01% |
115,394
+4,163
| +4% | +$38.9K |
|
|
NPKI
4185
NPK International
NPKI
$1.15B
| $1.03M | ﹤0.01% |
164,270
+91,727
| +126% | +$597K |
|
4186
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$686M
| $1.03M | ﹤0.01% |
15,842
+2,375
| +18% | +$149K |
|
4187
CrossAmerica Partners
CAPL
$862M
| $1.03M | ﹤0.01% |
56,921
+1,489
| +3% | +$26.5K |
|
4188
Cars.com
CARS
$653M
| $1.03M | ﹤0.01% |
83,985
+31,237
| +59% | +$364K |
|
4189
Stride
LRN
$3.33B
| $1.03M | ﹤0.01% |
50,411
+15,634
| +45% | +$334K |
|
|
TSI
4190
TCW Strategic Income Fund
TSI
$213M
| $1.03M | ﹤0.01% |
177,888
+1,218
| +0.7% | +$7.05K |
|
|
NAGE
4191
Niagen Bioscience
NAGE
$241M
| $1.02M | ﹤0.01% |
237,924
+27,971
| +13% | +$99.4K |
|
|
LGF.A
4192
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.02M | ﹤0.01% |
95,985
+32,632
| +52% | +$301K |
|
4193
Astronics
ATRO
$3.72B
| $1.02M | ﹤0.01% |
43,862
+13,034
| +42% | +$320K |
|
4194
Uranium Energy
UEC
$5.63B
| $1.02M | ﹤0.01% |
1,110,386
-166,536
| -13% | -$161K |
|
4195
Evolus
EOLS
$500M
| $1.02M | ﹤0.01% |
83,565
+4,076
| +5% | +$57.5K |
|
4196
Ichor Holdings
ICHR
$2.43B
| $1.02M | ﹤0.01% |
30,521
+4,044
| +15% | +$121K |
|
4197
Telkom Indonesia
TLK
$14.7B
| $1.02M | ﹤0.01% |
35,636
-3,410
| -9% | -$98.8K |
|
|
BSTC
4198
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.02M | ﹤0.01% |
17,843
+1,900
| +12% | +$101K |
|
|
DOO
4199
Bombardier Recreational Products
DOO
$4.7B
| $1.01M | ﹤0.01% |
22,266
-1,997
| -8% | -$89.1K |
|
|
AIF
4200
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $1.01M | ﹤0.01% |
67,160
+15,916
| +31% | +$236K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.